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DObjective: This study was undertaken to delineate outcomes and to assess risk factors for in-hospital mortality
among Chinese patients undergoing coronary artery bypass grafting.
Methods: From 2007 to 2008, a total of 9838 consecutive adult patients undergoing coronary artery bypass
grafting were enrolled in the Chinese Coronary Artery Bypass Grafting Registry, which included 43 centers
from 17 province-level regions in China. This registry collected information on 67 preoperative factors and
30 operative factors believed to influence in-hospital mortality. The relationship between risk factors and in-
hospital mortality was evaluated by univariate and logistic regression analyses.
Results: Overall in-hospital mortality was 2.5%. Eleven risk factors were found to be significant predictors for
outcome: age (continuous), body mass index (continuous), left ventricular ejection fraction (continuous), pre-
operative New York Heart Association functional class III or IV, chronic renal failure, extracardiac arteriopathy,
chronic obstructive pulmonary disease, preoperative atrial fibrillation or flutter (within 2 weeks), preoperative
critical state, other than elective surgery, and combined valve procedure. Calibration with the Hosmer-
Lemeshow test was satisfactory (P ¼ .35), and the discrimination power was good (area under the receiver op-
erating characteristic curve, 0.81; 95% confidence interval, 0.79–0.84).
Conclusions: The risk profiles and in-hospital mortality of Chinese patients undergoing coronary artery bypass
grafting were determined from data in the most up-to-date multi-institutional database. Eleven variables were
demonstrated to be independent risk factors for in-hospital death after coronary artery bypass grafting. (J Thorac
Cardiovasc Surg 2012;144:355-9)Supplemental material is available online.
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The Journal of Thoracic and Cademand of patients who need revascularization with coro-
nary artery bypass grafting (CABG), Chinese institutions
and surgeons have elected to carry out increasing numbers
of CABG procedures. With little knowledge of the current
risk profiles of Chinese patients undergoing CABG, how-
ever, crude mortality rates have often been used as an indi-
cator for quality of care in China, which might bring
considerable bias in quality comparisons among institutions
and might even interfere with providing surgical service for
high-risk patients who could gain most from surgical treat-
ment, despite increased risk.2 We embarked on this study
with the intent of establishing the risk profile of adult pa-
tients undergoing CABG in China and to determine the
in-hospital mortality among these patients. This study is
based on the most up-to-date multi-institutional Chinese da-
tabase. This effort is especially important because recent lit-
erature has revealed that conclusions drawn from Western
databases (eg, EuroSCORE) might not be suitable for this
cohort of patients.3MATERIALS AND METHODS
Database Setup
The Chinese CABG Registry is a national multi-institutional study with
the aim of exploring the risk factors and clinical outcomes for Chinese pa-
tients undergoing CABG. Its steering group was set up to include a numberrdiovascular Surgery c Volume 144, Number 2 355
Abbreviation and Acronym
CABG ¼ coronary artery bypass grafting
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Dof Chinese cardiac surgeons and epidemiologists with an interest in the
field of CABG surgical risk from Fuwai Hospital. Forty-three participating
institutions from 17 province-level regions in mainland China (there are 31
province-level regions in mainland China, including 22 provinces, 4 di-
rectly controlled municipalities, and 5 autonomous regions, excluding
Hong Kong, Macau, and Taiwan) enrolled a total of 9838 adult patients un-
dergoing CABG from January 2007 to December 2008, with data prospec-
tively collected (Figure 1). Because of the economic imbalance inmainland
China, most of the cardiac centers that were capable of carrying out CABG
procedures were located in the eastern part of the country, as shown by the
participating centers of our registry (Figure 1). Patients from all over main-
land China (all 31 province-level regions, plus patients from Macau) re-
ceived treatment provided by institutions of our registry, however, which
enabled our database to be representative of the whole Chinese population
(Figure 2). Detailed information on patient demographic characteristics,
preoperative risk factors, operative risk factors, and in-hospital mortality
were collected. The data collected for the registry included 67 preoperative
factors (Appendix E1) and 30 operative parameters (Appendix E2) that
were selected on the basis of our clinical experience previous published lit-
erature concerning the risk factors for CABG procedures.
Quality Control of Data
Two reviewers from the data processing center abstracted a random
sample of 5% to 10% of medical records through on-site auditing at
a 6-month interval. The data submitted by the hospitals were compared
with information in the medical records. When disagreement occurred,
a physician adjudicated the disagreement to determine the final value.
This final database, referred to as the Chinese Cardiovascular Surgical Reg-
istry database, was then scrutinized carefully. A total of 274 patients were
found to have incomplete data records: of them, 5 patients were without
listed age, 70 without listed weight, 52 without listed height, 205 without
listed ejection fraction values, 1 without data regarding unstable angina,
2 without data regarding cardiogenic shock, and 80 without listed New
York Heart Association functional class. Some of these patients had
more than 1 missing data field. Considering the fact that they only ac-
counted for a very small proportion of our patients, we imputed missing
continuous variables (age, weight, height, and ejection factor values; for
weight and height, different mean values were used for the sexes) with
mean values and missing categoric variables with negative values (unstable
angina, cardiogenic shock, New York Heart Association stage) so that pa-
tients who might have experienced the end point (in-hospital death) would
not be excluded from analysis simply for 1 or 2 missing variables among
the many examined.
Statistical Analysis
Statistical analysis was performed with SPSS statistical software (ver-
sion 13.0; IBMCorporation, Armonk, NY). All the possible risk factors as-
sociated with early mortality were screened with c2 tests for categoric
covariates and t tests or Wilcoxon rank sum tests for continuous covariates.
Those variables with P values greater than .2 were excluded. A stepwise
multivariate logistic regression was then performed with a backward
method (criteria for entry and removal of variables were P<.05 and P>
.10), with 1 variable eliminated at a time. Stability of the model was
checked every time a variable was eliminated. When all statistically non-
significant variables had been eliminated, Hosmer-Lemeshow c2 test was
used to evaluate the calibration and the area under the receiver operating
characteristic curve was used to assess how well the model could356 The Journal of Thoracic and Cardiovascular Surgdiscriminate between patients who lived and patients who died. Multicol-
linearity of the identified risk factors was checked with tolerance and infla-
tion statistics.
Informed consent was provided by participants. This study was ap-
proved by the local institutional review board and ethics committee (insti-
tutional review board and ethics committee of Fuwai hospital, approval
number 219).
RESULTS
In all, 43 surgical centers from 17 province-level regions
in mainland China participated in the project, giving a total
of 9838 consecutive adult patients. After imputation of the
missing variables, all 9838 patients were entered into our
analysis. Elective procedures accounted for 97.1%, isolated
CABG accounted for 87.7%, and off-pump procedures ac-
counted for 52.4%. Overall in-hospital mortality was 2.5%.
Risk Profiles
Multivariate analysis identified 11 risk factors as being
related to in-hospital mortality: age (continuous), body
mass index (continuous), left ventricular ejection fraction
(continuous), preoperative New York Heart Association
functional class III or IV, chronic renal failure, extracardiac
arteriopathy, chronic obstructive pulmonary disease, preop-
erative atrial fibrillation or flutter (within 2 weeks), preoper-
ative critical state, other than elective surgery, and
combined valve procedure. The definitions and statistical
characteristics of the risk profiles are listed in Table 1. Mul-
ticollinearity diagnostics with tolerance statistics excluded
multicollinearity of the 11 factors.
The calibration of the model was satisfactory (P ¼ .35
with Hosmer-Lemeshow), and the discrimination power
was good (area under the receiver operating characteristic
curve, 0.81; 95% confidence interval, 0.79–0.84).
Clinical Outcomes
The overall in-hospital mortality (defined as any in-
hospital death) was 2.5%. For patients undergoing elective
procedures, the in-hospital mortality was 2.3% while the
mortality rate was 11.1% for patients undergoing non-
elective surgeries (Definition of nonelective surgery was
as specified in Appendix E2). The mortality rate for
isolated-CABG was 2.0%, and the rate increased to 6.3%
when CABG was combined with valve procedures. For pa-
tients without any identifiable risk factors (whether signifi-
cant or not), the baseline mortality was 0.5%.
DISCUSSION
Necessity of First Large-Scale Study in China
In a phenomenon known as the epidemiologic transi-
tion.1 the incidence of coronary artery disease in China is
increasing with an unprecedented speed. It is estimated to
be 98 per 100,000 and may further increase by more than
50% in the next 2 decades.4 This foreshadows an enormous
disease burden in the world’s most populous country, withery c August 2012
FIGURE 1. Distribution of institutions participating in this registry.
TABLE 1. Risk factors for in-hospital mortality in Chinese patients
undergoing CABG
Variable
Odds
ratio
95% Confidence
interval
P
value
Age (continuous) 1.06 1.04–1.08 <.001
Body mass index (continuous) 0.91 0.87–0.96 <.001
Left ventricular ejection fraction
(continuous)
0.97 0.95–0.98 <.001
New York Heart Association class
III or IV
1.92 1.43–2.58 <.001
Chronic renal failure 2.40 1.27–4.53 .007
Extracardiac arteriopathy 4.38 2.30–8.33 <.001
Chronic obstructive pulmonary
disease
2.46 1.36–4.45 .003
Preoperative atrial fibrillation or
flutter
1.97 1.33–2.92 .001
Preoperative critical stage 2.20 1.29–3.75 .004
Nonelective surgery 2.38 1.30–4.35 .005
Combined valve surgery 2.51 1.76–3.57 <.001
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Dcurrently more than 1.3 billion people. Parallel to the in-
crease of patients with coronary artery disease, CABG pro-
cedures have also shown a dramatic increase. In 1992, the
total number of CABG procedures all over China was fewer
than 500,5 whereas in 2008, more than 5000 CABG proce-
dures were carried out in 17 institutions of our registry. De-
spite this rapid growth in surgical procedures, little is known
about the current risk profiles of Chinese patients undergo-
ing CABG. There have been attempts to use the ‘‘ready-
made’’ experience from the published literature derived
from large databases of Western countries. Databases like
that of the Society of Thoracic Surgeons6 are proprietary,
however, and other existing models, such as the Euro-
SCORE,7 have failed to provide accurate risk assessments
in a cohort of Chinese patients undergoing CABG,3 suggest-
ing different risk profiles in the Chinese population than forFIGURE 2. Distribution of patients from different province-level regions
of China included in this registry.
The Journal of Thoracic and Ca‘‘more mature’’ CABG populations in the developed world.
Identification of the risk factors for contemporary Chinese
patients undergoing CABG is thus a prerequisite for in-
formed consent by patients and for the assessment of the
quality of care among different institutions, which might
aid in the allocation of medical resources.
Eleven variables were identified as independent risk fac-
tors for in-hospital mortality among Chinese patients under-
going CABG. Most of these factors had been described by
other studies,8,9 such as age and chronic renal failure;
however, at least 2 important differences between our
population and other databases were observed. First, the
percentage of off-pump surgery was very high in our cohort
of patients (52.4%). Of all the off-pump procedures, most of
them (98.3%) were carried out on the basis of the doctor’s
decision. We have noticed that the percentage of off-pump
CABG was much lower in Western population (eg, in US,
the rate was 20% in 200610), and our database contained
higher rate of off-pump procedures, reflecting the preference
and confidence of Chinese surgeons for off-pump techniques
in contemporary China. This may be attributable to tech-
nique advances (eg, anesthesia, myocardial protection)
achieved in recent years and to prolonged training required
for cardiovascular surgeons before one could carry out
CABG procedures in the majority of centers of this regis-
try.11 Second, reoperation (previous cardiac surgery or previ-
ous CABG), was not a significant risk factor for in-hospital
death after CABG in our patients, although most other
non-Chinese studies have included it as a heavily weighted
risk factor.7,9,12,13 This may be due to 2 reasons: (1)
patients who had previous cardiac surgery accounted for
very small portion of the whole cohort (previous cardiac
surgery, 1.1%; previous CABG, 0.3%), and (2) these
patients often received care in the best heart centers inrdiovascular Surgery c Volume 144, Number 2 357
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CABG history underwent reoperation in Beijing,
Shanghai, or Tianjin (direct-controlled municipalities with
the best medical resources in this country); of them, 40%
of patients received care from China’s largest heart center,
Fuwai Hospital. In addition, these low reoperation rates
may not only reflect the current situation in China but also
be representative for other developing countries where
coronary artery disease is becoming increasingly prominent.
Our multi-institutional database, which is based on pa-
tients from all over China (a country with 1 fifth of the
world’s population), is a pioneering attempt to explore the
risk factors and to describe the clinical outcomes in the Chi-
nese CABG population. Moreover, to our knowledge, this is
also among the first attempts of its kind in Asia, which nur-
tures more than 2 thirds of the world’s population. Con-
ducted at exactly the point of epidemiologic transition,
this study may well demonstrate the risk profiles in a less
mature CABG population relative to those in the developed
world. CABG is a relatively recent and growing procedure
in China and other developing countries.
This large multicenter database has provided useful infor-
mation concerning the risk profiles and clinical outcome in
Chinese heart centers. As the very first of its kind and with
its up-to-date data, our study would help Chinese surgeons
with better evaluation of their patients, help Chinese patients
with clearer informed consent, and help politicians to allo-
cate valuable medical resources better. In addition, we
hope that our experience could be further applied to other
Asian populations (such as India) that are now going through
the same problem of epidemiologic transition as China.
Limitations
Three major limitations are noted in this study: First, this
study used in-hospital mortality as the major end point,
whereas the science of outcome analysis has recommended
a longer interval (eg, 6 months) for a more accurate evalu-
ation of early risk for patients undergoing CABG.14 Longer
follow-up of patients is therefore needed in further studies
to delineate more accurate and complete risk profiles for
Chinese patients undergoing CABG.
Second, this study, conducted at the point of epidemio-
logic transition, would probably be out of date in the near
future, as previous studies have demonstrated that risk pro-
files of coronary artery operations change with time.15 The
characteristics of Chinese patients undergoing CABG are
changing rapidly, with more complicated clinical scenarios
arising (such as growing rates of reoperation). Because
most other studies have focused on more mature CABG
populations, our study on a less mature patient cohort
may contribute to the literature dealing with the increasing
numbers of patients in exactly this less mature population.
Moreover, a baseline graph was portrayed at this ‘‘pre-
explosion’’ moment, which may help in the future.358 The Journal of Thoracic and Cardiovascular SurgThird, because this study was based on an exclusively
Chinese population and was validated with the same data
set, great caution should be taken if our experience is to
be applied to other populations. Nevertheless, it may still
be of some importance for populations that are at the point
of epidemiologic transition.CONCLUSIONS
The risk profiles and clinical outcomes of Chinese pa-
tients undergoing CABG were analyzed with data from
the most up-to-date multi-institutional database. Eleven
variables were demonstrated to be independent risk factors
for post-CABG in-hospital death.
This study was conducted on behalf of the Chinese CABG
Registry Study. The consultant surgeons involved are (in alpha-
betical order by family name) Haisheng Chen, Liangwan Chen,
Xin Chen, Yifan Chi, Zhaoyun Cheng, Nianguo Dong, Tianxiang
Gu, Jianguo Hu, Shengshou Hu, Tao Han, Shulin Jiang, Ye Kong,
Jiali Liang, Jianshi Liu, Su Liu, Yingze Li, Xiaocheng Liu,
Zhiyong Liu, Chengchao Sun, Peixiong Su, Liang Tao, Chuzhong
Tang, Fenglin Wang, Junsheng Wang, Chunsheng Wang, Mingy-
ing Wu, Ruobin Wu, Shuming Wu, Dong Xu, Feng Xiao, Jiyan
Xie, Mingdi Xiao, Yingbin Xiao, Ping Xu, Xiangming Xu,
Zhiyun Xu, Song Xue, Biao Yuan, Chuanrui Yang, Dinghua Yi,
Qiang Zhao, Kaiguang Zhang, Shunye Zhang, Wenjun Zhen,
and Chengwei Zou. We acknowledge the assistance of each cen-
ter listed here for collecting and validating the data. We also
thank the Chinese CABG Registry Study database working staff
(Yan Zhao, Huan Ren, Na Tian, and Zhiming Zhu) for their in-
dustrious efforts. The 43 centers (in alphabetic order) participat-
ing in the Chinese CABG registry study (2007–2008) were
Affiliated Hospital of Jining Medical College, Beijing Chao-
Yang Hospital, Beijing Friendship Hospital, Beijing Hospital,
Beijing Tongren Hospital, Beijing Xuanwu Hospital, Changhai
Hospital of The Second Military Medical University, China-
Japan Friendship Hospital, Fujian Provincial Hospital, Fujian
Medical University Union Hospital, Fuwai Hospital, Guangdong
Cardiovascular Institute, Guangdong Gaozhou People’s Hospital,
Henan Anyang People’s Hospital, Henan Provincial People’s
Hospital, Jiangsu People’s Hospital, Nanjing Firtst Hospital, Pe-
king University First Hospital, Peking University People’s Hospi-
tal, Ruijin Hospital of Shanghai Jiao Tong University, Shandong
University Qilu Hospital, Shandong Provincial Hospital, Shang-
hai Renji Hospital, Shanghai Chest Hospital, Shanghai First Peo-
ple’s Hospital, Shanxi Cardiovascular Hospital, Teda
International Cardiovascular Hospital, The Affiliated Hospital
of Medical College Qingdao University, The First Hospital of
China Medical University, The First Affiliated Hospital of Wenz-
hou Medical College, The General Hospital of Jinan Military re-
gion, The Second Affiliated Hospital of Harbin Medical
University, The Second Hospital of Hebei Medical University,
The Second Xiangya Hospital of Central South University, Tian-
jin Chest Hospital, Tongji Medical College of Huazhong Univer-
sity of Science and Technology Union Hospital, Wuhan Asia
Heart Hospital, Xijing Hospital of The Fourth Military Medical
University, Xinqiao Hospital of The Third Military Medicalery c August 2012
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east University, Zhongshan Hospital Fudan University.A
C
DReferences
1. Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the devel-
oping world. Am Heart J. 2004;148:7-15.
2. Hannan EL, Siu AL, Kumar D, Racz M, Pryor DB, Chassin MR. Assessment of
coronary artery bypass graft surgery performance in New York. Is there a bias
against taking high-risk patients? Med Care. 1997;35:49-56.
3. Zheng Z, Li Y, Zhang S, Hu S, Chinese CABG Registry Study. The Chinese cor-
onary artery bypass grafting registry study: how well does the EuroSCORE pre-
dict operative risk for Chinese population? Eur J Cardiothorac Surg. 2009;35:
54-8.
4. Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, et al. Future cardiovas-
cular disease in China: Markov model and risk factor scenario projections from
the coronary heart disease policy model—China. Circ Cardiovasc Qual Out-
comes. 2010;3:226-7.
5. Zhang H, Hu S. [History of the grafting of coronary artery bypass]. Zhonghua Yi
Shi Za Zhi. 2001;31:148-52. Chinese.
6. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The Society of Tho-
racic Surgeons National Cardiac Surgery Database: current risk assessment. Ann
Thorac Surg. 1997;63:903-8.
7. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. Eu-
ropean system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardi-
othorac Surg. 1999;16:9-13.The Journal of Thoracic and Ca8. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk
for evaluating the results of surgery in acquired adult heart disease. Circulation.
1989;79(6 Pt 2):I3-12. Erratum in: Circulation. 1990;82:1078.
9. Eagle KA, Guyton RA, Davidoff D, Ewy GA, Fonger J, Gardner TJ, et al. ACC/
AHA guidelines for coronary artery bypass graft surgery: executive summary
and recommendations: A report of the American College of Cardiology/Ameri-
can Heart Association Task Force on Practice Guidelines (Committee to revise
the 1991 guidelines for coronary artery bypass graft surgery). Circulation.
1999;100:1464-80.
10. Puskas JD, Steele M. Would you like some cardiopulmonary bypass with your
coronary revascularization? Circulation. 2007;116:1756-8.
11. Hu S, Zheng Z, Yuan X,WangW, Song Y, Sun H, Xu J. Increasing long-term ma-
jor vascular events and resource consumption in patients receiving off-pump cor-
onary artery bypass: a single-center prospective observational study. Circulation.
2010;121:1800-8.
12. Reid C, Billah B, Dinh D, Smith J, Skillington P, Yii M, et al. An Australian risk
prediction model for 30-day mortality after isolated coronary artery bypass: the
AusSCORE. J Thorac Cardiovasc Surg. 2009;138:904-10.
13. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, et al. Risk
stratification of in-hospital mortality for coronary artery bypass graft surgery. J
Am Coll Cardiol. 2006;47:661-8.
14. Osswald BR, Blackstone EH, Tochtermann U, Thomas G, Vahl CF, Hagl S. The
meaning of early mortality after CABG. Eur J Cardiothorac Surg. 1999;15:
401-7.
15. Miller DC, Stinson EB, Oyer PE, Jamieson SW, Mitchell RS, Reitz BA, et al.
Discriminant analysis of the changing risks of coronary artery operations:
1971–1979. J Thorac Cardiovasc Surg. 1983;85:197-213.rdiovascular Surgery c Volume 144, Number 2 359
Acquired Cardiovascular Disease Zheng et al
A
C
DAPPENDIX E1. SIXTY-SEVEN PREOPERATIVE
RISK FACTORS FOR UNIVARIATE ANALYSIS
Sex, age (in years), height (in meters), weight (in kilo-
grams), body mass index (in kilograms per square meter),
body surface area (in square meters), history of smoking,
family history of coronary artery disease (immediate family
members with diagnosed coronary artery disease or sudden
cardiac death before 55 years of age), diabetes mellitus, hy-
perlipidemia (total cholesterol>5.18 mmol/L, low-density
lipoprotein 3.37 mmol/L, high-density lipoprotein<0.78
mmol/L, or triglycerides >1.69 mmol/L), hypertension,
chronic renal failure (documented history or any previous
serum creatinine level>176 mmol/L), cerebrovascular acci-
dent (documented history of coma 24 hours or central
nervous system dysfunction 72 hours), endocarditis
(documented history or diagnosis with blood culture and
cardiac ultrasonography), chronic obstructive pulmonary
disease (long-term use of bronchodilators or steroids for
lung disease), immunosuppressive therapy (within 30
days before surgery), extracardiac arteriopathy (any 1 or
more of the following: claudication, carotid occlusion or
>50% stenosis, previous or planned intervention on the
abdominal aorta, limb arteries, or carotids), previous car-
diac surgery, previous coronary artery bypass grafting, pre-
vious valve surgery, previous percutaneous balloon
valvuloplasty, previous percutaneous coronary interven-
tion, previous permanent pacemaker placement, previous
history of noncardiac surgery, history of myocardial infarc-
tion, recent myocardial infarction (<21 days), heart failure
(within 2 weeks), unstable angina (rest angina requiring in-
travenous nitrates until arrival in the anesthetic room), car-
diogenic shock (lasting until arrival in the anesthetic
room), cardiopulmonary resuscitation (within 2 hours),
preoperative persistent ventricular tachycardia or fibrilla-
tion (within 2 weeks), preoperative III atrioventricular
block (within 2 weeks), preoperative atrial fibrillation or
flutter (within 2 weeks), preoperative critical stage (any 1
or more of the following: preoperative cardiogenic shock,
ventricular fibrillation or flutter, preoperative intra-aortic
balloon pump implantation), New York Heart Association
functional class, Killip staging (for patients with acute
myocardial infarction), Canadian Cardiovascular Society
class (for patients with angina), serum creatinine, total
cholesterol, triglycerides, low-density lipoprotein, high-359.e1 The Journal of Thoracic and Cardiovascular Surgdensity lipoprotein, hemoglobin, high-sensitivity C-reac-
tive protein, erythrocyte sedimentation rate, left carotid
artery lesion, right carotid artery lesion, left renal artery
stenosis, right renal artery stenosis, number of involved
coronary arteries, left main stenosis, left descending
stenosis, circumflex stenosis, right coronary stenosis, graft
stenosis, left ventricular ejection fraction (assessed by
echocardiography at the last time before surgery), ventric-
ular aneurysm, pulmonary hypertension (systolic
pulmonary arterial pressure>60 mm Hg), valve stenosis
or insufficiency, aortic stenosis, mitral stenosis,
tricuspid stenosis, pulmonary stenosis, aortic insufficiency,
mitral insufficiency, tricuspid insufficiency, pulmonary
insufficiency
APPENDIX E2. THIRTY OPERATIVE RISK
FACTORS FOR UNIVARIATE ANALYSIS
Nonelective surgery (Emergency or salvage surgery, with
emergency surgery defined as unscheduled surgery required
on the same day because of refractory angina despite maxi-
mal medical therapy, acute evolving myocardial infarction
within 24 hours before surgery, aortic dissection, percutane-
ous coronary intervention failure, or other reasons, and
salvage surgery defined as operations on patients who had
cardiopulmonary resuscitation before arrival in the anes-
thetic room), on-pump surgery, time of extracorporeal cir-
culation, time of aortic crossclamping, beating-heart
surgery (on-pump surgery with ventricular fibrillation is
considered beating-heart surgery), site of cannula, aortic
crossclamp, intra-aortic balloon pump support during or
after coronary artery bypass grafting, ventricular assistance
device, heart transplant, extracorporeal membrane oxygen-
ation, number of grafts, combined valve surgery (surgical
procedures with either valve), procedure on aortic valve,
procedure on mitral valve, procedure on tricuspid valve,
procedure on pulmonary valve, repair for ventricular aneu-
rysm, repair of septal rupture, excision of heart tumor, re-
pair of congenital heart defects, laser drilling, repair of
injured cardiac muscle, implantation of permanent pace-
maker, surgery for atrial fibrillation, procedure on thoracic
aorta, cell transplant, hybrid procedure (planned hybrid
procedure with percutaneous coronary intervention and
coronary artery bypass grafting), carotid procedure, postin-
farction septal ruptureery c August 2012
